Navigation Links
Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
Date:1/5/2009

Endo's management team will host a conference call and audio Webcast on Monday, January 5 at 5:30 p.m. EST to discuss this transaction. Interested parties may call 866-700-5192 (domestic) or 617-213-8833 (international) and enter code 56825052. Please dial in 15 minutes prior to the scheduled start time. A replay of the call will be available until 12:00 a.m. EST on January 12 by dialing 888-286-8010 (domestic) or 617-801-6888 (international), passcode 16542748.

A simultaneous audio Webcast of the call may be accessed by visiting www.endo.com. A replay of the Webcast will be available until 12:00 a.m. EST on January 12. The replay can be accessed by clicking on "Events" in the Investor Relations section of the Website. Please connect to the Website at least 15 minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.

Analyst Meeting Information

Endo Pharmaceuticals will host an analyst meeting in New York on Tuesday, January 6, 2009 to discuss this transaction further. Registration begins at 11:30 a.m. EST, and the presentation and Webcast will take place from 12:00 to 2:00 p.m. EST. For more information or to register for the Endo Pharmaceuticals analyst meeting, please email analystday@burnsmc.com or call 212-300-8324. The analyst meeting will also be simultaneously Webcast from Endo's Website at www.endo.com.

About Indevus Pharmaceuticals

Indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The company's approved prod
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... has released a new blog post explaining how to ... Clients can review important auto insurance quotes online, by ... advantages for clients who need affordable financial security for ... coverage for their vehicles can purchase a policy at ... agencies offer important discounts and drivers can learn more ...
(Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com has been undergoing ... to run maintenance on our shipping facilities to update ... PR Director. "It disrupted our regular shipping schedule but ... on track after having completed the maintenance." , Now, ... which has not allowed some calls to come in ...
(Date:4/18/2015)... 18, 2015 PHOENIX, ARIZONA – In ... with 11 other secure destruction professionals across the United ... (CSDS). He will now display “CSDS” as a professional ... before the National Association of Information Destruction 2015 Annual ... Grapevine, Texas. Of the 20 people who took the ...
(Date:4/17/2015)... ERGO-Pedic Products, LLC, which produces therapeutic ... products to help a broader range of people plagued ... the second most common visitors to doctors. , “The ... to help relieve sitting pain. Then, only a couple ... happy customers later, we began getting questions from those ...
(Date:4/17/2015)... April 17, 2015 From the day Dr. ... the Texas non-profit organization has empowered young people to create ... to bring fresh water and the Gospel to all ... University. Between March 17 and 27, students, faculty and staff ... Liberians with fresh water and the Good News of Jesus. ...
Breaking Medicine News(10 mins):Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2
... and National Experts Address Smart Solutions to Keep Program,Accessible ... and the,Pennsylvania Medical Society hosted a panel discussion with ... Doctors in Medicare could,leave the program after scheduled pay ... harder for people in the program to find a ...
... Increasing the level of,Quitline smoking cessation services and ... way to reduce smoking rates, according to,two new ... a peer-reviewed,publication of the British Medical Journal. Both ... for Health Research in Portland,the Oregon Health Department, ...
... beyond, Typical ,Best, and ,Worst, Lists and ... Affecting the Quality of ... risks and the,quality of medical care travelers encounter can ... International Healthcare Rating,System, high standards of care go beyond ...
... Catholics for Choice Publishes Results of Four-Continent Poll Gauging,Catholic ... 29 Even in the face of an,AIDS epidemic ... to lift its ban on condoms. A new multinational ... using condoms is prolife,because it prevents the spread of ...
... in the Yale University-affiliated community health clinic was so,much ... almost be looking in a,mirror. The man was African ... in New Haven, Conn., (Photo: http://www.newscom.com/cgi-bin/prnh/20070531/DCTHFNS1 ... the man was coughing,feverish, and losing weight for no ...
... Specialty chemicals,maker Albemarle Corporation (NYSE: ALB ... referred to as DBM, methylene dibromide, or,MDB) by ... or as contracts allow., (Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO ... to cover higher costs, in particular,higher raw material, ...
Cached Medicine News:Health News:AARP Pennsylvania Hosts Panel on Strengthening Medicare 2Health News:Smoking Cessation Rates Double With Intensive Counseling and Free Nicotine Replacement Therapy, Studies of 20,000 Smokers Show 2Health News:Smoking Cessation Rates Double With Intensive Counseling and Free Nicotine Replacement Therapy, Studies of 20,000 Smokers Show 3Health News:Smoking Cessation Rates Double With Intensive Counseling and Free Nicotine Replacement Therapy, Studies of 20,000 Smokers Show 4Health News:MEDEX 360m Rates the State of Global Medical Care for Travelers 2Health News:New Poll Shows Catholics Around the World Believe Good Catholics Can Use Condoms 2Health News:Take the Test, Take Control: World AIDS Day 2007 2Health News:Albemarle to Raise Prices of Dibromomethane 2
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research and ... addition of the "Corporate Reputation of Pharma in ... 2nd edition" report to their offering. ... perspectives from 130 patient groups with an interest in ... companies (and of the pharma industry as a whole) ...
(Date:4/17/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of cancer and diseases of the central ... three of its most advanced oncology programs at the ... Annual Meeting being held from April 18-22, 2015 ... The presentation on the BNC105 program describes ...
(Date:4/16/2015)... , April 16, 2015  Hologic, Inc. ... cervical cancer screening study i published on-line ... peer-reviewed journal of the American Cancer Society. ... and the University of Pittsburgh Medical Center, supports current consensus ... recommend that women 30-65 years of age be ...
Breaking Medicine Technology:Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
... 2011 Johnson & Johnson (NYSE: JNJ ... at a meeting with the investment community today.  Senior ... will review how the business plans to address some ... pharmaceutical market growth with an optimized product portfolio, robust ...
... May 26, 2011 Cell Therapeutics, Inc. ("CTI") (NASDAQ: ... its previously announced pipeline strategy, CTI has identified a ... candidate being investigated in the field of cancer immunotherapy. ... therapeutics activate macrophages and dendritic cells to present foreign ...
Cached Medicine Technology:Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 2Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 3Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 4Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 5CTI Provides Update on New Product Acquisition Strategy and Upcoming ASCO Events 2CTI Provides Update on New Product Acquisition Strategy and Upcoming ASCO Events 3CTI Provides Update on New Product Acquisition Strategy and Upcoming ASCO Events 4CTI Provides Update on New Product Acquisition Strategy and Upcoming ASCO Events 5
Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
3.2 mm Keratome, double bevel, sharp sides, ang. 1 Ea as quantity....
LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles....
Microprocessor-based isolated electrosurgical generator, designed for all general surgical procedures. Unit includes the Valleylab adaptive REM system and Instant Response technology....
Medicine Products: